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In this review of the chemistry, biochemistry and chemical pathology
of the bile pigments I am well aware that I shall ask many more questions
than I am able to answer. It seems appropriate that the subject should be
considered under the five headings: -Chemistry; Formation from Haem
Proteins; Transport in the Blood; Conjugation and Transport to the Bile;
and Changes in the Gut. I shall conclude with a brief account of the early
labelled bilirubin. Because investigation of the pathological significance
of the chemical changes undergone in the body is possible only if the
chemical structures of the bile pigments are accurately known, my depart-
ment in London has been very much concerned during the last 15 years
with the chemistry of the bile pigments. The work I shall describe has
been carried out in collaboration with Dr. NICHOLSON, Dr. KULCZYCKA,
Dr. COLE, Dr. PETRYKA and more recently by Mr. STOLL and Miss
LEMMON.
Chemistry
As is well known, the bile pigments all possess a linear tetrapyrrolic
structure with various numbers and arrangements of double bonds and
various extents of the conjugation of those double bonds (Fig. 1). To this
complexity there is added the complications caused by isomeric changes,
such as by prototropy, whereby a bilirubin is readily converted to a bili-
verdin (1) (Fig. 2) and d-urobilin converted to a rhodin (2) (Fig. 3). We
have been particularly interested in the structure of the urobilins in which
only the two central pyrrole rings are linked by a double bond (Fig. 1) and
our investigations have led to the isolation of two urobilins (3) additional
to the i-urobilin, d-urobilin and stercobilin known to be present in faeces
(Fig. 4). These new urobilins (Table 1) consist of an optically inactive
form of d-urobilin and an optically active form of i-urobilin. Since then,
WATSON (4) has described the isolation from faeces of a urobillin which
resembled d-urobilin in its chemical reactions, crystalline form and melting
point which was optically inactive, and a dl-stercobilin has been prepared
by the catalytic hydrogenation of bilirubin (5). An optically inactive
149
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Fig. 1 Structures of the bile pigments
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Fig. 2 Possible mechanism of prototropy in bilirubin
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Fig. 3 Possible mechanism of prototropy in end ring of d-urobilin
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Table 1. Recently Isolated Urobilins
Pigment I Molecular Formula Molecular Weight Stability
Racemised d-Urobilin (3) C33H40N406 588 Moderately stable
Racemised d-Urobilin (4) C33H40 or 42N406 588 or 590 Moderately stableor d-Urobilin IXa:
d-Urobilin IXa:(3J C33H42N406 590 Unstable
dl-Stercobilin (5)
(catalytic hydrogenation C33H46N406 594 Stable
of bilirubin)
Tetrahydro-i-Urobilin(6) C33H46N406 594 Stable
(synthetic)
tetrahydro i-urobilin has been synthesised by PLEININGER and LERCH (6).
The cause of the high optical rotations of some urobilins is of parti-
cular interest because those of d-urobilin and stercobilin are among the
highest known. We have studied the changes in optical rotation occurring
on the formation of zinc complexes (7) (Fig. 5) and the resulting reduction
in optical rotation leads us to believe that the optical rotation is due to the
helical shape of the molecule which was made more planar by formation
of the zinc complex. The behaviour of stercobilin on complex formation,
however, was anomolous (Fig. 6) in showing a series of changes in optical
rotation which until recently have defied explanation. However, a closer
examination of the changes in the optical rotatory dispersion spectrum on
zinc complex formation has revealed that this behaviour can be explained
entirely by the changes during complex formation in the shape of the curve
relating optical activity to wavelength (Fig. 7). The optical rotatory dis-
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Fig. 4 Currently accelJted struc-
tures for the "CLASSICAL'" urobilins
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Fig. 5 Change of optical activIty of
d-urobilin hydrochloride in chloroform on
addition of zinc acetate
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Fig. 7 Optical rotatory dispersion by
chloroform solution of stercobilin hydro-
chloride in the presence of increasing amounts
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persion curve of stercobilin when 1.2 moles of zinc acetate are added
crosses that with 2. 1 moles of zinc acetate added at a wavelength of about
550 m/i.. At 589 m/i. (the mean wavelength of the sodium lines) the optical
rotation falls with the addition of about 1 atom of zinc. The rotation then
returns to approximately its original value on the addition of a second
atom of zinc and then progressively falls on the addition of further
amounts of zinc.
We had at one time hoped that mass spectrometry of the bile pigments
would throw light on their structure and indeed in an earlier paper (8) we
believed that we had demonstrated that stercobilin was a double molecule,
which would have explained many earlier observations. However, it is now
known that stercobilin is split into two components under the conditions
of temperature and pressure in the mass spectrometer, and that our earlier
interpretation of this change was erroneous.
We were interested in the problem of isomer types of bile pigments
(Fig. 8) and NICHOLSON, NICOLAUS and I showed that all naturally occurr-
ing bile pigments were predominately IX~ in type, i. e. they were formed
from protoporphyrin by rupture at the a-methene bridge (9). ,The identi-
fication of isomer type depends on the specific mixture of monopyrrolic
acids formed on oxidation with permanganate. However, Dr. PETRYKA
(l0, 11), first in my department and later confirming his work in Minnea-
polis, has shown that early-labelled stercobilin may contain a small amount
Fig. 8 Isomeric verdins theoretically formed by fission of protoporphyrin
IX, and their oxidation products the pyrrolic acids (I) and (II). M = CH3;
V=CH: CH2; P=CH2·CH2·C02H
(1) • (II)
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of an isomer other than the IXa form and this has recently been supported
by the work of Miss Lemmon in my laboratory. She has developed a more
sensitive gas chromatographic method for the detection of the pyrrolic acids
formed on oxidation. It seems likely that the weakness of the NICOLAUS (12)
method of investigations is the very low yield of pyrrolic acids formed by
oxidation and there is, therefore, a probability that small amounts of
isomers, other than the IXa type, would not be detected, in that insuffici-
ent pyrrolic acids would be formed for identification. There is urgent
need for a more thorough re-investigation of this method.
Formation of Bile Pigments from Haem Proteins
I pass now to consider the formation of bile pigment from haemoglobin
and other haem proteins. It would be presumptuous of me to describe in
detail the major advances made in this country concerning the action of
haem a·methene oxygenase in forming formyl biliverdin (13, 14)(Fig. 9). It
Fig. 9 Possible mechanism of haemoglobin degradation via
haemoglobin-haptoglobin complex.
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was the profound importance of this work that inspired me to arrange for
Dr. Osamu NAKAJIMA to visit my department to establish the IX~ nature
of the product of this enzymic pathway. Although MURPHY, O'HEOCHA
and O'CARRA (15) in Ireland and more recently LEVIN (16) in the United
States have found difficulty in preparing an active enzyme, Dr. NAKAJIMA
has repeated his work and we have succeeded in showing that the bile
pigment formed is mainly, if not exclusively, IXa in type (17). It is our
belief that these workers have been unable to prepare an active liver
extract and Professor O'HEOCHA is sending one of his colleagues to our
department to prepare such an extract under Dr. N AKAJIMA'S guidance.
Dr. NAKAJIMA himself has also become interested in elucidating the true
substrate of the oxygenase and he is at present examining the substrate
activity of the sub.units of haemoglobin and of methaemalbumin. It will
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also be of importance to examine the activity in this respect of haem pro-
teins such as cytochrome P450 which has received so much attention recently.
Of particular interest is that the highest oxygenase activity is present in
the kidney; Dr. NAKAJIMA has found that haemolysis induced by phenyl-
hydrazine increases the haem a-methene oxygenase activity in the liver by
three times thus raising it to the same level as that observed in the kidney.
We are hoping in the near future to examine especially the high activity
in the kidney in respect of the cytochrome P460 • It seems very likely that
this may be an important source of bile pigment formation (18).
Transport to the Liver, Conjugation and Transport to the Bile
Passing to the problems of transport, conjugation and excretion, I do
not intend to consider these in detail, although there are a number of
fascinating problems, especially in relation to the disaggregation of the
bilirubin-protein complex in passing from the blood plasma to the liver
cell, the transport of the bile pigment to the site of conjugation and the
transfer of the conjugated material to the bile. Much work has been done
in this country and by Dr. BILLING (19) and by Professor SCHMID (20), both
of whom have recently visited Japan and have told you of their important
work in these fields. There are, however, a number of outstanding pro-
blems. What is the abnormality in the various forms of non-haemolytic
retention jaundice, not all of which seem to be due to an enzyme defici-
ency? Furthermore, there is need for further investigation into the be-
haviour of the biliverdin reductase, which is clearly of importance in
reduction of biliverdin to bilirubin, the form in which the bile pigments
are transferred from the reticulo endothelial system to the liver.
Dr. Roger WILLIAMS and Dr. Richard THOMPSON of my medical school
are investigating some of these aspects. They have been particularly in-
terested in examining the mode of action of phenobarbital on the serum
bilirubin. The first observation in this field was that of CATZ and YAFFE
(21) who showed an increased liver glucuronyl transferase in mice treated
with phenobarbital. YAFFE and, independently, CRIGLER and GOLD (22)
then observed a reduction in the serum bilirubin concentration on giving
phenobarbital to children with the Crigler.Najjar syndrome, while GAR.
TNER (23) could find no change in the serum bilirubin of Gunn rats treated
for two months with the drug. SCHMID (18) investigated the effect on the
incorporation of labelled glycine into the biliary bilirubin in untreated rats
and rats treated with phenobarbital. There was increased synthesis of the
drug metabolising enzymes cytochrome b6 and P460 • He observed a con·
siderable increase in the early labelled fraction. Recently, Dr. WILLIAMS
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and Dr. THOMPSON (24) have studied the effect of phenobarbital on the
serum bilirubin of 4 patients with biliary cirrhosis of long standing. In
these, chronic cholestasis was prominent. In all, phenobarbital treatment
resulted in a fall in the plasma bilirubin. In these patients the plasma
bilirubin had been relatively constant at a raised level for nearly a year.
I t is difficult to understand the significance of these contradictory findings
and although one is tempted to speculate on the relationship between these
effects of phenobarbital on plasma bilirubin on induction of mitochondrial
cytochromes and in inducing acute attacks in patients with acute porphyria,
there is urgent need for much more work in this field.
Changes in the Gut
The bile pigments are excreted in the bile into the duodenum in con-
jugated form and the changes occurring during its passage down the gut
include hydrolysis, hydrogenation, dehydrogenation and degradation
of tetrapyrro1ic structure (25). Only some of the resulting substances
are absorbed from the gut. Because the chemical, physical and biological
properties of free and conjugated bilirubin are very different, the fate of
bile pigments in the gut and other changes they undergo must depend upon
the extent of hydrolysis of conjugated bilirubin and upon the site of that
hydrolysis. The ease with which bilirubin glucuronide is hydrolysed and
the known presence within the gut of bacterial and intestinal glucuroni.
dases suggests that the free pigments might be liberated from glucuronides
in the intestinal tract. It is not yet known whether the conjugates are
hydrolysed before or after reduction, although a quantitative conversion
of bilirubin glucuronide to urobilinogen but not of bilirubin is brought
about in vitro by normal faecal flora in broth cultures (26). A little biliru-
bin normally remains unreduced in the intestine and is excreted in the
faeces but it is not known if this is conjugated or not. Since, however,
urobilin and urobilinogens are the main faecal tetrapyrrolic pigments
excreted, considerable quantities of bilirubin glucuronide probably nor-
mally reach the colon.
The conversion of bilirubin in the gut to the final products, the
urobilinogens, is generally accepted as a stepwise reduction effected by
dehydrogenases of the intestinal bacteria (27), but surprisingly little is
known of the detailed course of the reaction. Outstanding problems con·
cern the role of the glucuronide radical, the role of co.factors in the bile,
the order with which and the sites at which the various pigments arise and
whether reduction alone explains their formation. The proportions of
i.urobilin and d-urobilin and stercobilin which can be obtained from the
8
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faeces are quite unpredictable and are independent of disease (28). The
absorption of urobilinogen in the colon, its normal return to the liver with
re-excretion in the bile constitutes the enterohepatic circulation first postu-
lated by MULLER (29) and repeatedly reviewed since.
Urobilinogen absorbed from the intestine is excreted in the urine in
large amounts in the early and in the recovery stages of hepatogenous
jaundice. Early demonstrations of the enterohepatic circulation believed
to be responsible for this depended on such experiments as the appearance
of urobilinoid substances in the bile after enemata, containing mesobili-
rubinogen, had been administered to patients with biliary fistulae. Recent
methods by SCHMID and his colleagues for the production of isotopically
labelled bilirubin (30) and of mesobilirubinogen (31) have permitted un-
equivocal demonstration of the intestinal absorption of mesobilirubinogen
but not of urobilin. There is also absorption of bilirubin but not of
conjugated bilirubin (32, 33). Absorption and enterohepatic circulation of
[UC] mesobilirubinogen have been demonstrated after introduction of the
labelled pigment into either the terminal ileum or the duodenum of rats
and in man (31,34). There is slower absorption from the terminal ileum
than from the jejeunum or duodenum and this may be the result of the
reduced surface available for absorption as well as of adsorption of the
urobilinogen on the faecal solids. Urobilinogenuria has long been regarded
as resulting from impaired re-excretion into the bile due to liver disease,
to biliary trauma and infection. It is possible that the presence of liver
disease may permit invasion of the ileum by micro-organisms and of uro-
bilinogen formation which may occur higher in the intestine than normal.
Absorption is more rapid and complete in this part of the gut so that
urobilinogenuria may reflect enhanced intestinal chromogen absorption as
well as impaired hepatic excretion (31). Infection of the biliary tract by
certain micro-organisms capable of forming d-urobilin from bilirubin
glucuronide is associated with d-urobilinogenuria and this may be due to
the spread of these organisms up the gut. d-urobilinogen may thus be due
to absorption of this chromogen from the gall bladder itself or from the
upper part of the small intestine. LESTER and SCHMID have successfully
shown that in both rats and in man absorption of bilirubin can occur
throughout the entire length of the small intestine and of the colon (32, 33).
In the human there seems to be less intestinal hydrolysis of conjugated
bilirubin than in rats so that in normal man little enterohepatic circulation
of bilirubin occurs. In human subjects with the congenital defect of hepatic
bilirubin conjugation, crystalline labelled bilirubin was isolated in con-
siderable quantity from the stools after injection of [ltC] bilirubin (35). It
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must, therefore, be concluded that bilirubin can pass also from blood
through intestinal mucosa of the lumen. This is an excretory route which
possibly occurs normally to a minor extent but is of especial value when
hepatic excretion is limited. An attempt has been made unsuccessfully to
increase excretion in subjects with defective conjugation of bilirubin by
this route, by the oral administration of cholestyramine (36). This is a
resin which can absorb bilirubin.
For many years my department has been concerned with the precise
chemical structure and estimation of the faecal bile pigments and we are
now in complete agreement with C. J. WATSON and his group that the
proportions of the three urobilins and of their colourless precursors are
entirely fortuitous and dependent on diet and intestinal flora (28). Never-
theless, there remains the problem of the colour of normal faeces; this
has recently been raised by WITH (37) at a conference in London.
Closely related to this problem is the pathway of elimination of bile
pigments in the Cunn rat and in the Crigler-Najjar syndrome. Both
SCHMID (35) and BILLING and I (38) have found that labelled bilirubin is in
part degraded to substances other than the known bile pigments. In this
connection, a study of the yellow pigment found in the bile of Cunn rats
and in the bile of these subjects would be worthy of investigation.
The Early Labelled Bilirubin
The problem of the early-labelled bilirubin has become extremely
complex since London and his colleagues in New York (39) and my
own group in London (40) showed that a proportion of the bile pigment
was formed from a source or sources other than the haemoglobin of
erythrocytes at the end of their life span. This early-labelled bile pigment
is produced in excess in the following pathological conditions: pernicious
anaemia, sickle cell anaemia, thallassaemia, aplastic anaemia, congenital
porphyria, shunt hyperbilirubinaemia, coproprotoporphyria. Subsequent
work by SCOTT and me (41) and by others showed that this bile pigment
fraction labelled during the first 10 days after administration of isotopically
labelled glycine was increased by increased erythropoiesis (42).
Professor YAMAMOTO with ISRAELS and their colleagues showed that
labelled bilirubin appeared within about 1 hr. and persisted for 4-6 days
in the bile of dogs with biliary fistula (43). They were therefore the first
to shown how rapidly this fraction was synthesised. Later they showed
that this early-labelled fraction must consist of at least 2 components (44,
45). The first of these components appeared in the plasma within 90
minutes and lasted 24 hr.: the other did not reach a maximum until 3-5
10
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days after the glycine. This second component, the so.called erythropoietic
component, was affected by changes in the rate of erythropoiesis and its
time of appearance approximated to that expected for the incorporation
of (I·C] -glycine into the maturing red cell. The first component was not
affected by erythropoiesis and was thought to derive from a source other
than the bone marrow. Such a double or multiple origin of the early-
labelled pigment is better shown by changes in isotope incorporation into
the bile pigment of the plasma or of the bile rather than into that of the
faecal stercobilin, because the faecal bile pigment can often be isolated
only from pooled collections of faeces. Nevertheless, we ourselves have
noticed during isotope experiments that double peaks sometimes occur
during the first few days in the labelling of faecal stercobilin but have
hesitated to attribute significance to such double peaks because of the
possibility of experimental error. Such a double peak was found with a
child with congenital hyperbilirubinaemia, who we described in a paper
published with Dr. BILLING (38). We have, however, unequivocally con-
firmed the existence of the double peak in the labelling of faecal stercobilin
in an adult patient with congenital hyperbilirubinaemia.
As shown by Professor YAMAMOTO, ISRAELS and their colleagues the
erythropoietic and non-erythropoietic components can be distinguished by
the use of isotopically labelled a-aminolaevulic acid (ALA) since this
precursor is poorly incorporated into haem and therefore poorly incorpo-
rated into the erythropoietic component of bile pigment but rapidly in-
corporated into the non.erythropoietic fraction (46). My own group with
that of RIMINGTON has shown that in erythropoietic protoporphyria a sub-
stantial proportion of the excreted protoporphyrin became labelled at the
same time as the early-labelled fraction of bile pigment and that there was
a strong possibility that the non-erythropoietic component was derived from
hepatic haems (47). As stated in our publication, the amounts of stercobilin,
coproporphyrin and protoporphyrin isolated from the faeces each day were
sufficient to demonstrate a considerable excess of early labelled bile pig-
ment. The maximum labelling of these three compounds occurred at the
same time so that this bile pigment fraction must have been formed with
the faecal coproporphyrin and protoporphyrin from a common precursor.
Unfortunately only small amounts of protoporphyrin could be isolated from
the red cells necessitating considerable dilution of the isolated material to
permit measurement of the 15N content. Only 3 measurements were signifi-
cantly different from the zero excess of 15N. We have recently repeated
this experiment with a second subject and using a more sensitive mass
spectrometer, and have now convinced ourselves that the isotope content
11
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of the free protoporphyrin in the red cells is at the most one-twelfth that
of the faecal protoporphyrin. We feel therefore that in this condition a
substantial proportion of the faecal porphyrin and of the early-labelled
bile pigment must be derived from a source other than the maturing red
cells and that this source is very probably the liver (48).
The Minneapolis group led by SCHWARZ have shown that in biliary
fistula dogs, much of the early-labelled bilirubin could be accounted for
by the turnover of label in the easily-split haem of liver and to a lesser
extent of the kidney (49). Moreover, SCHMID and his group have confirmed
a hepatic origin of part at least of the early-labelled bile pigment and have
shown that the perfused isolated liver can synthesise bilirubin from ALA
(50).
Recently ISRAELS and his colleagues have studied the incorporation of
[l~CJ -ALA into the bilirubin of the bile and into the hepatic and kidney
haems in biliary fistula rats (46). They obtained convincing evidence that
a fraction of the labelled bilirubin was synthesised within a few minutes of
the injection of the ALA and that this very early-labelled fraction was
unlikely to be related to the turnover of those haem fractions of the liver
and kidney which had hitherto been investigated. On the other hand, a
substantial proportion of the labelled bilirubin excreted between 2 and 24
hr. after injection was probably derived from the turnover of the major
haem proteins of the liver and kidney.
These findings strongly suggested that the early-labelled bile pigment
consists of three fractions. The early-labelled pigment, in addition to the
erythropoietic fraction, consists of 2 other components, one certainly
derived from the turnover of the major haem proteins of the liver and
kidney and a second component formed too rapidly to be accounted for by
catabolism of the major haem proteins. However, even in liver homoge-
nates incubated with [;4C] -ALA, newly synthesized haem and bilirubin
appeared within 5 minutes and this may be accepted as evidence that the
very early bilirubin is derived from a haem protein with an unusually
rapid turnover.
The late non· erythropoietic fraction may well be derived from liver
catalase or cytochrome, the half-lives of which are about 24 hr. but the
rapidly-turning over haem protein responsible for the very early non-ery-
thropoietic fraction is less easily identified. This very early bilirubin which
is most readily detected in the plasma might well be derived from some
other organ than the liver for it is difficult to accept that it should be
secreted into the blood stream by the liver only to be re-excreted by that
organ. In this connection, one wonders if the kidney were the organ
12
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concerned, especially since the highest activity of the enzyme haem a-
methene oxygenase is found in the kidney at any rate of the guinea.pig.
However, there may be species differences in the proportions of the three
fractions of the early.labelled bile pigment. Indeed there is some evidence
that the non.erythropoietic components may be less significant in normal
man than in some experimental animals such as the rat and the dog.
Nevertheless, the earlier observations have been extended to human sub.
ects (45) in whom, after [14CJ-ALA, the specific activity of plasma bilirubin
showed a single peak at 1-2 hr. while bilirubin isolated from bile collected
with a T-tube in the common bile duct exhibited its peak at 6-12 hr. but
maintained a shoulder at 12-24 hr.
There then seems little doubt that the early labelled bile pigment is
obtained from at least 3 sources:
( i) in association with erythropoiesis
(ii) from rapidly turning.over haem such as liver cytochromes
or catalase
(iii) from very rapidly turning-over haem perhaps in extrahepa-
tic tissues as well as in the liver.
The source of this last fraction is of particular interest. SCHMID has
produced some evidence that it might be derived from the mitochondrial
cytochrome P458' This is associated with the smooth part of the endoplasmic
reticulum and the levels and turnover rate are more than sufficient to
account for this fraction of the early-labelled pigment. SCHMID has found
when rats are treated with phenobarbital to induce increased amounts of
this enzyme, the very early labelled peak is greatly increased. This provided
strong evidence that the very early labelled fraction might be derived
from this cytochrome, but other effects of barbiturates, such as in biliary
cirrhosis, are more difficult to explain.
There is urgent need to investigate bilirubin metabolism before and
during phenobarbital thera py using labelled bilirubin. There is also need
to investigate the contributions made by the three early-labelled bile
pigment fractions to the total bile pigment production. In this connection,
similar investigation could be well worth while in all the conditions in which
the early.labelled bile pigment is increased. It has alway been assumed
that the early.labelled pigment in erythropoietic or congenital porphyria
is erythropoietic in origin. Is this so? In erythropoietic protoporphyria
the peak of labelling of faecal stercobilin is very sharp at 4 days. May
this be the second non-erythropoietic fraction? It may well be. All the
other conditions require similar investigation using [14C J-ALA, but will
not be really practical until more sensitive methods are divised for the
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measurement of the specific activity of plasma bilirubin in the absence of
hyperbilirubinaemia.
There are many other problems in need of answers. What is the cause
of the increased proportion of early-labelled bile pigment in extra hepatic
biliary obstruction? Why have double peaks been observed in the labelling
of faecal stercobilin in congenital hyperbilirubinaemia and only seldom in
other human subjects? Might this condition be due to passage to the liver
of increased amounts of bile pigments produced in other organs such as
the kidney? These are matters my department is at present investigating.
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